bicalutamide and cycloheximide

bicalutamide has been researched along with cycloheximide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lou, YR; Nazarova, N; Pennanen, P; Qiao, S; Tuohimaa, P1
Baron, S; Beaudoin, C; Communal, Y; Leotoing, L; Manin, M; Morel, L; Veyssiere, G1
Chuan, YC; Flores-Morales, A; Nordstedt, G; Pang, ST; Pousette, A; Skoog, L1
Lou, YR; Nazarova, N; Talonpoika, R; Tuohimaa, P1
Arasheben, A; Barski, A; Coetzee, GA; Cogan, JP; Frenkel, B; Jariwala, U; Jia, L; Neilson, JJ; Pregizer, S; Prescott, J; Shen, HC1
Brogley, M; Chinnaiyan, A; Dhanasekaran, S; Hofer, MD; Kuefer, R; Lapensee, EW; O'Mahony, OA; Pienta, KJ; Rehman, H; Robins, DM; Rubin, MA; Steinkamp, MP1

Other Studies

6 other study(ies) available for bicalutamide and cycloheximide

ArticleYear
Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 85, Issue:1

    Topics: Androgen Antagonists; Anilides; Calcitriol; Cerulenin; Cycloheximide; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthases; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured

2003
Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells.
    The Journal of biological chemistry, 2004, Apr-09, Volume: 279, Issue:15

    Topics: Anilides; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Activation; Epithelial Cells; Escherichia coli; Glutathione Transferase; Humans; Ligands; Mice; Models, Genetic; Nitriles; Phosphatidylinositol 3-Kinases; Phosphorylation; Plasmids; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Serine; Signal Transduction; Threonine; Time Factors; Tosyl Compounds; Transcription, Genetic; Transfection

2004
Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
    Oncology reports, 2004, Volume: 11, Issue:6

    Topics: Androgen Antagonists; Androgens; Anilides; Collagenases; Cycloheximide; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Matrix Metalloproteinase 13; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured

2004
5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.
    The Prostate, 2005, May-15, Volume: 63, Issue:3

    Topics: Androgen Receptor Antagonists; Androgens; Anilides; Calcitriol; Cycloheximide; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Drug Interactions; Flutamide; Gene Expression Regulation, Enzymologic; Humans; Male; Nitriles; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Steroid Hydroxylases; Tosyl Compounds; Tumor Cells, Cultured; Vitamin D3 24-Hydroxylase

2005
Androgen receptor-mediated repression of novel target genes.
    The Prostate, 2007, Sep-15, Volume: 67, Issue:13

    Topics: Androgen Antagonists; Anilides; Cell Line, Tumor; Cycloheximide; Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Prostatic Neoplasms; Protein Synthesis Inhibitors; Receptor, Muscarinic M1; Receptors, Androgen; Receptors, Muscarinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tosyl Compounds; Transfection

2007
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
    Cancer research, 2009, May-15, Volume: 69, Issue:10

    Topics: Amino Acid Substitution; Anilides; Antineoplastic Agents; Autopsy; Cycloheximide; DNA Primers; Flutamide; Humans; Lymphatic Metastasis; Male; Mutation; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tosyl Compounds

2009